AndrewNeuschatzMD

Radiation Oncology • Tucson, AZ

Physician

Join to view full profile

Dr. Neuschatz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Neuschatz's full profile

Already have an account?

Office
Arizona Oncology
1845 W Orange Grove Rd Bldg 1
Tucson, AZ 85704
Phone+1 520-544-2919

Fax+1 520-544-2943
Is this information wrong?

Education & Training

Tufts Medical CenterResidency, Radiation Oncology, 1999 - 2003
Tufts Medical CenterInternship, Internal Medicine, 1998 - 1999
Georgetown University School of MedicineClass of 1998

Certifications & Licensure

AZ State Medical License 2003 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Top Doctors Tucson Lifestyle Magazine, 2013-2023
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014

Publications & Presentations

PubMed

3 citations
Tumor Bed Boost Omission After Negative Re-Excision in Breast-Conservation Treatment
Douglas W. Arthur, Laurie W. Cuttino, Andrew C. Neuschatz, Derrick Koo, Monica M. Morris, Harry D. Bear, Brian J. Kaplan, Kathy S. Dawson, David E. Wazer> ;Annals of Surgical Oncology. 2006 Apr 14
67 citations
Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy.
Andrew C. Neuschatz, Thomas A. DiPetrillo, Homa Safaii, Lori Lyn Price, Rupert Schmidt-Ullrich, David E. Wazer> ;Cancer. 2003 Jan 1
92 citations
Limited Resection for Non-Small Cell Lung Cancer: Observed Local Control With Implantation of I-125 Brachytherapy Seeds
Winnie Lee, Benedict D.T. Daly, Thomas A. DiPetrillo, Donna M. Morelli, Andrew C. Neuschatz, Jody Morr, Mark J. Rivard> ;The Annals of Thoracic Surgery. 2003 Jan 1
16 citations
Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery.
Michael J. Yunes, Andrew C. Neuschatz, Linda E. Bornstein, Stephen P. Naber, Vimla Band, David E. Wazer> ;International Journal of Radiation Oncology, Biology, Physics. 2002 Oct 1
86 citations
The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast
Andrew C. Neuschatz, Thomas A. DiPetrillo, Margaret M. Steinhoff, Homa Safaii, Michael J. Yunes, Marcia Landa, Maureen Chung, David E. Wazer, Blake Cady> ;Cancer. 2002 Apr 1
109 citations
Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer
David E. Wazer, David Lowther, Teresa Boyle, Kenneth Ulin, Andrew C. Neuschatz, Robin Ruthazer, Thomas A. DiPetrillo> ;International Journal of Radiation Oncology, Biology, Physics. 2001 May 1
28 citations
Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast.
Andrew C. Neuschatz, Thomas DiPetrillo, Homa Safaii, David Lowther, Marcia Landa, David E. Wazer> ;International Journal of Cancer. 2001 Jan 1
Join now to see all

Authored Content

Do Survival Statistics Make Sense to Cancer Patients?April 2019
How a Cancer Doctor Really Feels About Second OpinionsDecember 2018
The Little White Lies We Tell in Oncology10/8/2018
How to Deliver Bad NewsJuly 2018
Join now to see all

Press Mentions

How a Cancer Doctor Really Feels About Second OpinionsJanuary 17th, 2019

Hospital Affiliations

Northwest Medical CenterTucson, Arizona
TMC HealthCareTucson, Arizona

AndrewNeuschatzMD

Dr. Neuschatz is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Publications & Presentations

Authored Content

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.